A Randomized Control Trial on Intravenous Paracetamol Versus Intramuscular Tramadol as Intra Partum Labor Analgesia
1 other identifier
interventional
194
1 country
1
Brief Summary
ABSTRACT BACKGROUND: Labor pain is one of the most excruciating pain experienced by women. It affects maternal psychology and the course of labor causing apprehension, anxiety, and stress. Therefore there is a need for a safe and effective analgesic with minimal maternal and fetal side effects like intravenous paracetamol which has been shown to have great analgesic effect in labour with minimal maternal and neonatal side effects. OBJECTIVE: To compare intravenous paracetamol versus intramuscular tramadol as labour analgesia and to evaluate the incidence of side effects on mother and baby of both drugs. METHOD: This would be a hospital based randomized controlled trial comparing intravenous paracetamol to intramuscular tramadol as labour analgesia in pregnant women in active phase of labour in the department of obstetrics and gynecology at Alex-Ekwueme Federal University Teaching Hospital and St. Patrick Mile 4 hospital, Abakaliki. A total of 194 pregnant women in active phase of labour will be included in study after fulfilling the inclusion criteria. These women will be divided into 2 groups of 97 each. Group A will receive a 100ml intravenous infusion containing 1000mg of paracetamol single dose over 15min. Group B: will receive intramuscular tramadol hydrochloride 100mg single dose. Pain intensity of women with both drugs will be noted before administration of drug, one hour, two hours and three hours after administration of drug using the visual analog scale. Perinatal outcome will also be recorded. 10 ANALYSIS AND RESULTS: Data will be collated, tabulated and then statistically analyzed using Statistical Package for Social Science (IBM SPSS) software (version 24, Chicago II, USA). Continuous variables will be presented as mean and standard deviation (Mean ± 2SD) or median and range as appropriate, while categorical variables will be presented as frequencies and percentages. Chi-square test( or Fisher's exact test where applicable) will be used for comparison between groups for categorical variables while student t test or Mann-Whitney U test will be used for comparison between groups for continuous variables KEYWORDS Labour analgesia, intravenous paracetamol, intramuscular tramadol, visual analog scale, neonate, side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 pain
Started Jun 2022
Shorter than P25 for phase_2 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2022
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedApril 17, 2024
April 1, 2024
3 months
October 16, 2023
April 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean pain score
A standardized scale will be used to asses the mean pain score
4hours following administration of each agent
Study Arms (2)
Paracetamol group
EXPERIMENTALReceive intravenous paracetamol intrapartum as labour analgesia
Tramadol group
ACTIVE COMPARATORReceive intramuscular tramadol intrapartum as labour analgesia
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant women carrying live singleton fetuses at 37-42 weeks' gestational age.
- Pregnant women in active phase of labour; cervical dilatation ≥ 4cm
- Spontaneous onset of labour.
- Singleton pregnancy with vertex presentation
You may not qualify if:
- Women with clinical evidence of cephalopelvic disproportion
- Malpresentation
- Multiple pregnancy
- Previously scarred uterus (post myomectomy, post caesarean)
- Preterm labour
- Induced labour
- Antepartum hemorrhage
- Pregnancy induced hypertension
- History of known allergy to tramadol and paracetamol or opioids
- History of medical disorders
- Fetal distress
- Intrauterine fetal death
- Refusal to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AEFUTHA
Abakaliki, Ebonyi State, 234, Nigeria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
OGBO DR UZOMA, MBBS
Alex Ekwueme Federal University Teaching Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Double blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
October 16, 2023
First Posted
April 17, 2024
Study Start
June 3, 2022
Primary Completion
September 10, 2022
Study Completion
September 10, 2022
Last Updated
April 17, 2024
Record last verified: 2024-04